Form 4 for CI Cigna
Accepted 2024-03-28 00:00:00 ET · period of report 2024-03-26 · accession 0001225208-24-004608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-28 | 2024-03-26 | CI | Cordani David | COB, CEO, Dir | M - OptEx | $139.22 | +7,761 | 355.8K | +2% | +$1.08M |
| D | 2024-03-28 | 2024-03-26 | CI | Cordani David | COB, CEO, Dir | M - OptEx | $0.00 | -7,761 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2024-03-26 | M | A | 7,761 | $139.22 | 355,815 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-26 | M | D | 7,761 | $0.00 | 0 | D | $139.22 · 2017-03-01 to 2026-03-01 | 7,761 Common Stock, $.01 Par Value | (F3) This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |